TQC3721 Suspension for Inhalation

TQC3721 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TQC3721 Suspension for Inhalation, covering 2025-04-11 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation [Phase 2]